
Results 1 - 8 of 8 in Alphagan P, Brimonidine Tartrate (generic)
Alcon Posts 5.9 Percent Sales Growth for Third Quarter
Oct 27, 2009 - Alcon, Inc. reported global sales rose 5.9 percent to $1,614 million for the third quarter of 2009, or a 9.0 percent increase excluding the impact of foreign exchange fluctuations. Comment?
Alcon Posts 5.9 Percent Sales Growth for Third Quarter
Alcon, Inc. reported global sales rose 5.9 percent to $1,614 million for the third quarter of 2009, or a 9.0 percent increase excluding the impact of foreign exchange fluctuations. Comment?
News and FDA Updates for Allergan
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions. Comment?
Irvine-based Allergan is reporting this morning that it has won a patent infringement case against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd., Apotex, Inc. Comment?
Allergan Announces Victory in Brimonidine Patent Infringement Case
Allergan, Inc. has announced that the United States District Court for the District of Delaware ruled in favor of Allergan, Inc. Comment?
Allergan Announces Victory in Brimonidine Patent Infringement Case
Allergan, Inc. announced today that the United States District Court for the District of Delaware ruled in favor of Allergan, Inc. Comment?
Allergan Announces Victory in Brimonidine Patent Infringement Case
Allergan, Inc. announced today that the United States District Court for the District of Delaware ruled in favor of Allergan, Inc. Comment?
Aerobic exercise and intraocular pressure in normotensive and glaucoma patients.
With the increasing number of people participating in physical aerobic exercise, jogging in particular, we considered that it would be worth knowing if there are should be limits to the exercise with regard to the intraocular pressure of the eyes. Comment?